Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01717664
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG:
RHB-104
Sponsor
RedHill Biopharma Limited